Overview
David Gerber is an Oncologist in Dallas, Texas. Dr. Gerber is highly rated in 15 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Endoscopy.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6202 Harry Hines Blvd, Dallas, TX 75390
6201 Harry Hines Blvd, Dallas, TX 75235
UT Southwestern-Bill And Rita Clements Advanced Medical Imaging Center
Farrukh Awan is a Hematologist and an Oncologist in Dallas, Texas. Dr. Awan is highly rated in 39 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Texas Oncology, P.A.
Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is highly rated in 13 conditions, according to our data. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Tissue Biopsy.
Office
Larry Anderson is an Oncologist in Dallas, Texas. Dr. Anderson is highly rated in 25 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. David Gerber
How do I make an appointment with Dr. David Gerber?
You can book an appointment with Dr. David Gerber by calling their office at 214-645-4673. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. David Gerber a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. David Gerber is classified as an Distinguished expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. David Gerber specialize in?
While Dr. David Gerber is a Oncology, they have specific expertise in Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. David Gerber accept my insurance?
Dr. David Gerber accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 214-645-4673 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Gerber isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Gerber isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Gerber isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Gerber isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Gerber isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Gerber isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- MesotheliomaDr. Gerber isAdvanced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Gerber isAdvanced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Gerber isAdvanced. Learn about Neuroendocrine Tumor.
- Posterior Fossa TumorDr. Gerber isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Thymic Epithelial TumorDr. Gerber isAdvanced. Learn about Thymic Epithelial Tumor.
- Experienced
- Alveolar Soft Part SarcomaDr. Gerber isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AstrocytomaDr. Gerber isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Gerber isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Bone TumorDr. Gerber isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Gerber isExperienced. Learn about Brain Tumor.
- Embryonal Tumor with Multilayered Rosettes